Wollenhaupt-Aguiar B, Kapczinski F, Pfaffenseller B
In the category random sequence generation, the seven studies had a low risk
Most patients notice a significant reduction in appetite and cravings, and you may begin to see modest weight loss
For safety, all participants were followed for 6 weeks after the last dose was administered
6 The SURMOUNT-1 Trial found weight loss at all three doses of tirzepatide (5, 10, 15mg) with the most significant weight loss in the 15mg group with a reported 20.9% mean weight loss as compared to 3.1% for placebo over a 72 week trial
17 To perform a gastric POCUS exam, the gastric antrum is visualized with a 2-5-MHz curved-array probe with the patient in the right lateral decubitus position to provide the most accurate assessment of the gastric contents